FTC OKs Merck Plan To Shed Heartworm Plant To Merial
By Melissa Lipman ( February 11, 2015, 4:05 PM EST) -- The Federal Trade Commission on Wednesday signed off on Merck & Co. Inc.'s request to sell a canine heartworm medication plant to Merial Inc. after an antitrust review required under the deal Merck signed to win permission for its tie-up with Schering-Plough Corp....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.